1. Home
  2. BBNX vs SDHC Comparison

BBNX vs SDHC Comparison

Compare BBNX & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • SDHC
  • Stock Information
  • Founded
  • BBNX 2015
  • SDHC 2008
  • Country
  • BBNX United States
  • SDHC United States
  • Employees
  • BBNX N/A
  • SDHC N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • SDHC
  • Sector
  • BBNX Health Care
  • SDHC
  • Exchange
  • BBNX Nasdaq
  • SDHC Nasdaq
  • Market Cap
  • BBNX 967.6M
  • SDHC 794.4M
  • IPO Year
  • BBNX 2025
  • SDHC 2024
  • Fundamental
  • Price
  • BBNX $27.09
  • SDHC $17.64
  • Analyst Decision
  • BBNX Strong Buy
  • SDHC Hold
  • Analyst Count
  • BBNX 11
  • SDHC 4
  • Target Price
  • BBNX $28.09
  • SDHC $16.63
  • AVG Volume (30 Days)
  • BBNX 793.5K
  • SDHC 80.6K
  • Earning Date
  • BBNX 10-28-2025
  • SDHC 11-05-2025
  • Dividend Yield
  • BBNX N/A
  • SDHC N/A
  • EPS Growth
  • BBNX N/A
  • SDHC N/A
  • EPS
  • BBNX N/A
  • SDHC N/A
  • Revenue
  • BBNX $88,570,000.00
  • SDHC $998,173,000.00
  • Revenue This Year
  • BBNX $52.13
  • SDHC $1.27
  • Revenue Next Year
  • BBNX $36.07
  • SDHC $8.41
  • P/E Ratio
  • BBNX N/A
  • SDHC $80.15
  • Revenue Growth
  • BBNX 67.01
  • SDHC 10.26
  • 52 Week Low
  • BBNX $8.89
  • SDHC $15.00
  • 52 Week High
  • BBNX $30.47
  • SDHC $34.48
  • Technical
  • Relative Strength Index (RSI)
  • BBNX 58.70
  • SDHC 51.24
  • Support Level
  • BBNX $24.33
  • SDHC $17.10
  • Resistance Level
  • BBNX $29.22
  • SDHC $18.54
  • Average True Range (ATR)
  • BBNX 2.06
  • SDHC 0.95
  • MACD
  • BBNX 0.05
  • SDHC 0.05
  • Stochastic Oscillator
  • BBNX 52.89
  • SDHC 52.76

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.

Share on Social Networks: